1,2-aryl and heteroaryl substituted imidazolyl compounds for the

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

5142358, 514314, 514341, 514396, 514397, 514398, 514400, 544139, 546184, 546334, 5483114, 5483151, 5483154, 5483235, 5483255, 5483421, 5483425, A61K 3144, C07D40104, C07D21353

Patent

active

056166010

ABSTRACT:
A class of imidazolyl compounds is described for use in treating inflammation and inflammation-related disorders. Compounds of particular interest are defined by Formula I: ##STR1## wherein R.sup.1 -R.sup.6 are as described in the specification; or a pharmaceutically-acceptable salt thereof.

REFERENCES:
patent: 3487087 (1969-12-01), Sarett et al.
patent: 3682949 (1972-08-01), Sarett et al.
patent: 3719759 (1973-03-01), Sarett et al.
patent: 4560696 (1985-12-01), Carenzi et al.
patent: 4822805 (1989-04-01), Takasugi et al.
patent: 4822865 (1989-04-01), Takasugi et al.
patent: 5112532 (1992-05-01), Ninomiya et al.
patent: 5180732 (1993-01-01), Tomioka et al.
patent: 5185351 (1993-02-01), Finkelstein et al.
patent: 5207820 (1993-05-01), Wriede et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

1,2-aryl and heteroaryl substituted imidazolyl compounds for the does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 1,2-aryl and heteroaryl substituted imidazolyl compounds for the, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1,2-aryl and heteroaryl substituted imidazolyl compounds for the will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-539337

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.